Clinical Trials Browser

Unknown × Ramucirumab × Thoracic × Clear all

NCT03921671 2024-05-29

RELEVENT

Phase 2 Unknown

Neoplasm Metastasis, Thymoma

NCT04040361 2022-04-06

Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY)

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung